Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myocardial scintigraphy--25 years after start.

G Hör1

  • 1Department of Radiology, University of Frankfurt/Main, Federal Republic of Germany.

European Journal of Nuclear Medicine
|January 1, 1988
PubMed
Summary

Myocardial scintigraphy (MS) is a key nuclear medicine tool for assessing heart conditions. While not ideal for screening coronary heart disease (CHD), MS excels in detecting silent ischemia and guiding treatment for various heart diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined arthroscopic and radiation synovectomy in rheumatoid arthritis.

Der Orthopade·2017
Same author

Immunological profile of patients with ovarian-cancer under immunostimulation with murine monoclonal-antibodies.

International journal of oncology·2011
Same author

[Unusual, unilateral metastasis of a prostate-carcinoma and palliative rhenium-186 pain-therapy].

Nuklearmedizin. Nuclear medicine·2006
Same author

Radioisotope-guided surgery in patients with pheochromocytoma and recurrent medullary thyroid carcinoma: a comparison of preoperative and intraoperative tumor localization with histopathologic findings.

Cancer·2001
Same author

[Problems of differential diagnosis in the diagnosis of mediastinal and pulmonary metastases with F-a8-FDG PET].

Nuklearmedizin. Nuclear medicine·2000
Same author

Myocardial perfusion imaging and pilot certification.

European heart journal·2000

Area of Science:

  • Nuclear Medicine
  • Cardiology
  • Diagnostic Imaging

Background:

  • Myocardial scintigraphy (MS) has evolved as a significant diagnostic procedure in nuclear medicine.
  • Its development is closely linked to advancements in radiopharmaceuticals and imaging techniques.

Purpose of the Study:

  • To review the clinical applications of MS in diagnosing and managing coronary heart disease (CHD) and noncoronary heart conditions.
  • To evaluate the role of MS in risk stratification and therapy control for patients with heart disease.

Main Methods:

  • Review of recent literature from the US and Europe on MS techniques (planar, SPECT) and radiopharmaceuticals.
  • Analysis of clinical applications in CHD (single/multivessel disease, infarction) and other cardiac conditions.
  • Presentation of preliminary data using 111In-antimyosin and 99mTc-Isonitriles.

Main Results:

  • MS has limited value for CHD screening but is crucial for detecting asymptomatic ischemia/infarction.
  • The procedure aids in risk stratification (washout, uptake, dilation) and prognostication.
  • Correlative results show good agreement between 99mTc-isonitrile gated ventriculogram and conventional methods for ejection fraction.

Conclusions:

  • MS is vital for assessing ischemic heart disease, guiding therapy, and monitoring treatment effectiveness.
  • Emerging applications include systemic sclerosis, cardiac transplantation, and pediatric cardiology.
  • Advancements in digital radiology and contrast cardiography may further enhance MS utility.

Related Experiment Videos